USFDA completes inspection at Solara Active Pharma Sciences’ Mangalore facility

Solara Active Pharma Sciences Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 541540 | NSE: SOLARA

19 Nov 2025 Evaluate

Solara Active Pharma Sciences (Solara) has successfully completed the inspection carried out by the US Food and Drug Administration (USFDA) between August 25 and August 29, 2025 at Mangalore facility, Karnataka. The Agency has issued an EIR (Establishment Inspection Report) on November 18, 2025 and determined that the inspection classification of the facility is ‘Voluntary Action Indicated (VAI)’ and concluded this inspection as closed.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers

Company Name	CMP
Sun Pharma. Inds.	1848.00
Dr. Reddys Labs.	1198.65
Cipla	1408.75
Lupin	2084.00
Zydus Lifesciences	1190.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.